Cancer Genetics, Inc.
Cancer Genetics, Inc., a leading player in the oncology-focused genetic testing industry, is headquartered in the United States. Founded in 2000, the company has established itself as a pioneer in providing advanced genomic testing services that aid in the diagnosis and management of cancer. With a strong presence across major operational regions in North America and Europe, Cancer Genetics, Inc. offers a comprehensive suite of products, including molecular diagnostics and genomic profiling. What sets Cancer Genetics apart is its commitment to precision medicine, utilising cutting-edge technology to deliver tailored insights for oncologists and patients alike. The company has achieved significant milestones, including partnerships with prominent healthcare institutions, solidifying its market position as a trusted provider of cancer-related genetic information. Through its innovative approach, Cancer Genetics, Inc. continues to make strides in improving patient outcomes in the fight against cancer.
DitchCarbon Score
How does Cancer Genetics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cancer Genetics, Inc.'s score of 23 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cancer Genetics, Inc.'s reported carbon emissions
Cancer Genetics, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may still be engaged in sustainability initiatives typical of the industry, focusing on reducing environmental impact and enhancing operational efficiency. As the landscape of corporate climate responsibility evolves, Cancer Genetics, Inc. may consider establishing measurable targets and reporting frameworks to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cancer Genetics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
